Your browser doesn't support javascript.
loading
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.
van Hooren, Luuk; Vaccaro, Alessandra; Ramachandran, Mohanraj; Vazaios, Konstantinos; Libard, Sylwia; van de Walle, Tiarne; Georganaki, Maria; Huang, Hua; Pietilä, Ilkka; Lau, Joey; Ulvmar, Maria H; Karlsson, Mikael C I; Zetterling, Maria; Mangsbo, Sara M; Jakola, Asgeir S; Olsson Bontell, Thomas; Smits, Anja; Essand, Magnus; Dimberg, Anna.
Afiliação
  • van Hooren L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Vaccaro A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Ramachandran M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Vazaios K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Libard S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • van de Walle T; Department of Pathology, Uppsala University Hospital, Uppsala, Sweden.
  • Georganaki M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Huang H; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Pietilä I; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Lau J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Ulvmar MH; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Karlsson MCI; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Zetterling M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Mangsbo SM; Department of Neuroscience, Neurology, Uppsala University, Uppsala, Sweden.
  • Jakola AS; Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Olsson Bontell T; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Smits A; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Essand M; Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Dimberg A; Department of Clinical Pathology and Cytology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Nat Commun ; 12(1): 4127, 2021 07 05.
Article em En | MEDLINE | ID: mdl-34226552

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD40 / Estruturas Linfoides Terciárias / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD40 / Estruturas Linfoides Terciárias / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia País de publicação: Reino Unido